• A Hybrid Conference and Internet Event
• Sponsored by the Pharmaceutical Compliance Forum and the Asia Pacific Healthcare Industry Compliance Team
• Onsite at The Ritz-Carlton, Millenia, Singapore
• Online In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
• September 13 - 15, 2011
• www.AsianPharmaCongress.com

SINGAPORE -- PHARMA UPDATE NEWS SERVICE™ -- JUNE 29, 2011: The First Asia Pacific Pharmaceutical Compliance Congress, www.AsianPharmaCongress.com, September 13 - 15, 2011, will be held at the Ritz-Carlton, Millenia in Singapore. The Asia Pacific Pharma Congress is sponsored by the Pharmaceutical Compliance Forum and the Asia Pacific Healthcare Industry Compliance Team.

NEWLY CONFIRMED KEYNOTE SPEAKER

Kim Taylor Company Group Chairman, Johnson & Johnson, Pharmaceuticals, Asia Pacific, Singapore

FIRST ASIA PACIFIC PHARMACEUTICAL COMPLIANCE CONGRESS AND BEST PRACTICES FORUM September 13 - 15, 2011
ONSITE The Ritz-Carlton, Millenia Singapore	OR	ONLINE In your own office or home live via the Internet with 24/7 access for six months

FEATURING PRECONFERENCE SESSIONS Asia Pacific Code Update Asia Pacific Transparency, Disclosure and Aggregate Spend Issues AND MINI SUMMITS Mini Summit I: China Legal/Compliance Update Mini Summit II Asia Pacific Consumer Health Products Legal/Compliance Update Mini Summit III: Asia Pacific Acquisition/Merger Due Diligence Best Practices Mini Summit IV: India Legal/Compliance Update Mini Summit V: Interaction of UK Bribery Act, FCPA and Asia Pacific National Anti Corruption Laws Mini Summit VI: Managing Third Party Relationships Mini Summit VII: Responding to Government Investigations/Raids Mini Summit VIII: Clinical Trials Compliance Issues Mini Summit IX: Asia Pacific Fair Market Value Issues

SPECIALS SESSIONS The Role of Compliance in the Pharmaceutical Enterprise What is the 'Right Thing'? The Cultural Translation of Compliance The Evolving Legal/Compliance Environment in Asia Pacific Region Company Compliance Programmes with Respect to Third Party Intermediaries Korean Legal and Compliance Environment Overview of Chinese Pharma/Device Legal/Compliance Environment Overview of the Indian Pharma/Device Legal/Compliance Environment Cambodian Anti-Corruption Legislation Vietnam Code and Enforcement Update Amendments to Article 164 of the PRC Criminal Law Korean Duel Punishment Law Medicines Australia MCI Code of Medical Ethics Asia Pacific Market Access Issues The Whistleblower Reward Scheme (Dodd-Frank Act) Emerging Asia Pacific Transparency and Disclosure Laws Impact of US Sunshine Act on Pharma/Device Operations in Asia

FEATURED FACULTY

Ted Acosta, Esq. Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France Dr. Milind Antani Head, Pharma, Life Science and Healthcare Practice, Nishith Desai Associates, Legal & Tax Counseling Worldwide, Mumbai, India John Auerbach, MA Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China John T. Bentivoglio, Esq. Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice Washington, DC, USA Bridget Bourgeois Partner, Ernst & Young, New York, NY, USA Maija Burtmanis, LLB, LLM Regional Counsel, Japan/Asia Pacific, Novartis Vaccines, Former Regional Counsel, Pfizer Asia, Singapore William E. Buzzeo, MS Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA Li Cai, Esq. Regional R&D Counsel, Asia Pacific, Pfizer Inc., Shanghai, China John Cannings Partner, PricewaterhouseCoopers, Sydney, Australia Eugene Chen, Esq. Counsel, Hogan Lovells International LLP, Shanghai, China Hui Chen, Esq. Senior Corporate Counsel, Asia-Pacific Regional Lead, International Compliance Investigations, Pfizer, New York, NY, USA Hwa-Soo Chung, Esq. Partner and Chair, Health Law Group, Kim & Chang Law Firm, Soul, South Korea Seck Yee Chung, Esq. Partner and Chair, Vietnam Mergers & Acquisitions Practice, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Vietnam Irina Dragulev, Esq. Senior Corporate Counsel, Pfizer, New York, NY, USA Kimberly K. Egan, Esq. Partner and Co-Chair, Health Care Sector, DLA Piper LLP, Washington, DC Patricia A. Etzold, CPA Partner, Advisory Forensic Services, PricewaterhouseCoopers LLP, New York, NY, USA Qiao Gangliang, Esq. Senior Vice President, Siemens Ltd., China, General Counsel & Compliance Officer North East Asia, Beijing, China Ronald Goon Senior Director, Business Practices & Compliance, Office of Health Care Compliance & Privacy, Johnson & Johnson, Singapore Edward Bramley Harker Co-Leader, Global Pharmaceutical FMV Practice, PricewaterhouseCoopers LLP, London, UK Anwar Hashmi Senior Manager - Ethics, Tata Steel, Ltd., Jamshedpur, India Jeanine Jiganti, Esq. Chief Compliance Officer, Takeda Pharmaceuticals, Deerfield, IL, USA Thomas Kelly Vice President for Greater China, Sanofi-aventis, Beijing, China Homi R. Khusrokhan, FCA, M.Sc. (Econ.) London Special Advisor, Govt.-appointed Board of Satyam Computer Services Ltd.; Former Managing Director, Tata Chemicals Ltd., Mumbai, India Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter LLP, Washington, DC, USA Steven J. Kuzma, CPA, MBA Partner and Global Leader, Corporate Compliance Advisory Services, Ernst & Young, Atlanta, GA, USA Gareth Lee, Esq. Associate General Counsel, Asia Pacific, Allergan Inc., Singapore Michael K. Loucks, Esq. Partner, Skadden Arps LLP, Former First Assistant US Attorney, US Attorney's Office for the District of Massachusetts, Washington, DC Liz MacGillivray Head of Compliance AMAC Region (Asia Pacific, Middle East & African Countries), Novartis, Jumeirah Village, United Arab Emirates Carolyn Fitzhugh McNiven, Esq. Partner, DLA Piper LLP, Former Assistant United States Attorney and Deputy Chief of the Financial Frauds, and Special Prosecutions Section, US Attorney's Office, Northern District of Illinois, San Francisco, CA James R. Meehan Partner, Advisory Forensic Services, PricewaterhouseCoopers LLP, San Francisco, CA, USA Kathleen Meriwether, Esq. Principal, Ernst & Young, Former Assistant United States Attorney, US Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA, USA Chong Jin Ng, Esq. Assistant General Counsel, GlaxoSmithKline, Singapore Srinivasan Nurani, LLB, B.Com (Hons.) Vice President, Legal and Company Secretary, AstraZeneca India, Former General Manager, Legal and Company Secretary, Tata Industries Ltd., Bengaluru Area, India Vidya Rajarao Executive Director and Leader, Forensic Services, PricewaterhouseCoopers LLP, Mumbai, India Brian Riewerts Partner, Global Pharmaceuticals and Life Sciences, PricewaterhouseCoopers LLP, Baltimore, MD, USA Guillaume Roussel Vice President, Compliance Solutions EMEA, Cegedim Relationship Management, Paris, France Bretton G. Sciaroni, Esq. Partner, Sciaroni and Associates, Advisor to Royal Government of Cambodia, Phnom Penh, Cambodia Sue Seferian, Esq. Global R&D & Business Strategies Compliance Officer, Johnson & Johnson, New Brunswick, NJ, USA Arpinder Singh Partner and National Director, Ernst & Young, Mumbai, India Joseph A. Spiegler, Esq. Regional Compliance Counsel, Baxter Asia Pacific, Shanghai, China Dhinagar Subramanian, MD, MBA Head, Regional Market Access Asia-Pacific, Bayer (South East Asia) Pte Ltd, Singapore Sabina Sudan Vice President, Compliance Officer - Emerging Markets Asia Pacific (EMAP) & Japan, GlaxoSmithKline Pte Ltd., Singapore Felix Sutter Partner, Pharmaceutical and Life Sciences, PricewaterhouseCoopers LLP, Singapore Trudy Tan Regional Compliance Director, AstraZeneca, Singapore Nicola Teo, Esq. Senior Director - Legal, Business Development and RA/QA, St. Jude Medical, Hong Kong, China Geeta Thakerar, Esq. Regional Counsel, GlaxoSmithKline, Singapore Yuet-Ming Tham, Esq. Partner and Head, Regulatory, Compliance, & Investigations Group, Asia, DLA Piper LLP, Hong Kong Lim Kai Toh, MD Medical Affairs Manager, Pfizer, Singapore Paul Vibert, MBA Senior Vice President, Asia Pacific, Ferring Pharmaceuticals, Shanghai, China Vincent M. Walden, CFE, CPA, CITP Senior Manager, Fraud Investigation & Dispute Services, Ernst & Young, Dallas, TX, USA Jun Wei, Esq. Managing Partner, Beijing Office, Hogan Lovells International LLP, Beijing and Shanghai, China Kevin Yamaga-Karns, Esq. Senior Director of Legal Affairs & Compliance, Eli Lilly Japan KK, Kobe, Japan Chen Yang, LLB, LLM Partner, Global Life Sciences Team, Sidley Austin LLP, Beijing, China Ing Loong Yang, Esq. Partner, Global Life Sciences Team, Sidley Austin LLP, Singapore Jessie Yap, Esq. Chief Compliance Counsel, Asia Pacific/General Counsel, Australia & New Zealand, Covidien, Lane Cove, Australia Tom M. Zerull, CPA Senior Manager Ethics & Compliance, International Operations, Abbott, Singapore Tang Zhengyu, Esq. Partner and Chief Representative Shanghai Office, Sidley Austin, Shanghai, China

The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.

The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.